Cited by

• Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig.

  Steerenberg PA, De Jong WH, Geerse E, Beuvink A, Scheper RJ, Den Otter W, Ruitenberg EJ. Steerenberg PA, et al. Cancer Immunol Immunother. 1990;31(5):297-304. doi: 10.1007/BF01740938. Cancer Immunol Immunother. 1990. PMID: 2376047 Free PMC article.
• The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity.

  Berendt MJ, North RJ, Kirstein DP. Berendt MJ, et al. J Exp Med. 1978 Dec 1;148(6):1550-9. doi: 10.1084/jem.148.6.1550. J Exp Med. 1978. PMID: 309921 Free PMC article.
• Antigenicity of C 3 H mammary carcinoma in isogenetic hosts: preliminary studies.

  Bernard LJ, Allen M, Birchette C, Royal J, Walker M. Bernard LJ, et al. J Natl Med Assoc. 1973 Mar;65(2):108-10 passim. J Natl Med Assoc. 1973. PMID: 4570900 Free PMC article. No abstract available.
• Immunotherapy as an adjunct to surgery in the treatment of cancer.

  Eilber FR, Holmes EC, Morton DL. Eilber FR, et al. World J Surg. 1977 Sep;1(5):547-54. doi: 10.1007/BF01556179. World J Surg. 1977. PMID: 602232 No abstract available.
• The induction of tumours in the guinea-pig with methylcholanthrene and diethylnitrosamine and their propagation in vivo and in vitro.

  Dale MM, Easty GC, Tchao R, Desai H, Andjargholi M. Dale MM, et al. Br J Cancer. 1973 Jun;27(6):445-50. doi: 10.1038/bjc.1973.56. Br J Cancer. 1973. PMID: 4352789 Free PMC article.